Cancer patients with loss of HSP90AA1 expression were associated with a good prognosis after surgical treatment, and the absence of Hsp90α in tumor biopsy might serve as an indicator of positive clinical outcome (Buffart et al. 2012; Cheng et al. 2012). This evidence concerns the gene HSP90AA1 and cancer.